ESR1 and metastatic neoplasm: After applying chi-squared tests to the above results, it was concluded that distant metastatic tumors had a significantly higher probability to be Her-2-positive and PR-negative than did regional metastatic tumors, while there was no significant difference between ER expression in regional and distant metastatic diseases.